DKSH Holding AG (SWX:DKSH)
Switzerland · Delayed Price · Currency is CHF 56.60
-0.60 (-1.05%)
Jul 31, 2025, 5:34 PM CET
CTI BioPharma Cash Flow Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 195.4 | 214.8 | 182 | 201.1 | 223.9 | 157.1 | Upgrade |
Depreciation & Amortization | 120.4 | 119.5 | 124.2 | 122.2 | 123.7 | 124.5 | Upgrade |
Other Amortization | 3.4 | 3.4 | 4 | 4.3 | 4.5 | 4.7 | Upgrade |
Loss (Gain) From Sale of Assets | 7.4 | 2.9 | 2.1 | -1.3 | -10.6 | 5.8 | Upgrade |
Asset Writedown & Restructuring Costs | 3.7 | 3.7 | 3.9 | - | - | - | Upgrade |
Loss (Gain) From Sale of Investments | - | - | - | - | -32.5 | -9.6 | Upgrade |
Loss (Gain) on Equity Investments | -2.1 | -3.2 | 5.7 | 0.1 | 5.9 | -3.8 | Upgrade |
Stock-Based Compensation | 4 | 3.8 | 3.8 | 5.4 | 5.3 | 1.9 | Upgrade |
Other Operating Activities | 45.3 | 18.9 | 19.5 | 4.6 | 5.2 | 23.1 | Upgrade |
Change in Accounts Receivable | 28.3 | -63.2 | 7.8 | 4.2 | -51.2 | 113.9 | Upgrade |
Change in Inventory | -120.1 | -133.1 | 16.5 | -132.6 | -4.6 | 21 | Upgrade |
Change in Accounts Payable | 35 | 193.6 | 31.6 | 113.2 | 125.9 | -113.3 | Upgrade |
Operating Cash Flow | 322.5 | 362.9 | 393.1 | 321.9 | 393.2 | 325.3 | Upgrade |
Operating Cash Flow Growth | -12.55% | -7.68% | 22.12% | -18.13% | 20.87% | 10.57% | Upgrade |
Capital Expenditures | -35 | -33.7 | -30.7 | -36.6 | -44.8 | -31.2 | Upgrade |
Sale of Property, Plant & Equipment | 2.9 | 3.9 | 1.7 | 4.3 | 4.6 | 3.1 | Upgrade |
Cash Acquisitions | -34.4 | -34.5 | -62.1 | -433.6 | -91.5 | -63.7 | Upgrade |
Divestitures | 8.4 | - | -0.7 | - | - | -5.5 | Upgrade |
Sale (Purchase) of Intangibles | -7.3 | -7.9 | -21.6 | -48.3 | -10.2 | -4.3 | Upgrade |
Investment in Securities | - | -3.4 | -3.1 | 1.1 | - | -5.4 | Upgrade |
Investing Cash Flow | -65.4 | -75.6 | -116.5 | -513.1 | -147.9 | -102.9 | Upgrade |
Long-Term Debt Issued | - | 536.6 | 818.7 | 961.8 | 522.9 | 460.5 | Upgrade |
Long-Term Debt Repaid | - | -747.1 | -853 | -641.4 | -624.5 | -449.9 | Upgrade |
Net Debt Issued (Repaid) | -92.2 | -210.5 | -34.3 | 320.4 | -101.6 | 10.6 | Upgrade |
Repurchase of Common Stock | -2.9 | -3.1 | -6.2 | -6.3 | -7.3 | -2 | Upgrade |
Common Dividends Paid | -152.6 | -146.1 | -139.6 | -133.2 | -126.8 | -123.6 | Upgrade |
Other Financing Activities | -4.8 | -4.5 | -5.1 | 1.1 | -3.8 | 1.3 | Upgrade |
Financing Cash Flow | -252.5 | -364.2 | -185.2 | 182 | -239.5 | -113.7 | Upgrade |
Foreign Exchange Rate Adjustments | -24.1 | -1.2 | -40.6 | -28.1 | -12.9 | -20.5 | Upgrade |
Net Cash Flow | -19.5 | -78.1 | 50.8 | -37.3 | -7.1 | 88.2 | Upgrade |
Free Cash Flow | 287.5 | 329.2 | 362.4 | 285.3 | 348.4 | 294.1 | Upgrade |
Free Cash Flow Growth | -14.28% | -9.16% | 27.02% | -18.11% | 18.46% | 18.11% | Upgrade |
Free Cash Flow Margin | 2.57% | 2.96% | 3.27% | 2.52% | 3.13% | 2.73% | Upgrade |
Free Cash Flow Per Share | 4.41 | 5.06 | 5.57 | 4.38 | 5.35 | 4.52 | Upgrade |
Cash Interest Paid | 29.1 | 31.9 | 37.7 | 24.9 | 21.4 | 22.3 | Upgrade |
Cash Income Tax Paid | 75.8 | 74.7 | 81.2 | 81.7 | 73.8 | 61.2 | Upgrade |
Levered Free Cash Flow | 278.76 | 231.18 | 395.94 | 181.99 | 320.78 | 304.45 | Upgrade |
Unlevered Free Cash Flow | 313.14 | 251.3 | 420 | 198.24 | 334.28 | 318.64 | Upgrade |
Change in Net Working Capital | -16.2 | 42.3 | -143.8 | 42.7 | -81.4 | -66.1 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.